Market Cap$255.13B
P/E38.06x
PEG Ratio2.05
Div yield0.29%
Beta0.86
TMO Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)20.97%
Price vs S&P 500 (4W)6.07%
PEG Ratio2.05
VGM Score52.77
P/E Ratio (Annual)38.06x
Indicated Dividend Yield (Annual)0.29%
TMO Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | $5.71 | $6.03 | +5.58%(+$0.32) | |
| Q1 2026 | $5.24 | $5.44 | +3.79%(+$0.20) | |
| Q4 2025 | $6.45 | $6.57 | +1.87%(+$0.12) | |
| Q3 2025 | $5.50 | $5.79 | +5.32%(+$0.29) | |
| Q2 2025 | $5.23 | $5.36 | +2.55%(+$0.13) |
TMO Analyst Recommendations
Jun 2026
Jul 2026
Aug 2026
Sep 2026
4.18
4.14
4.11
4.11
Industry Peers — Measuring & Controlling Devices(11)
| Symbol | Value Score | Growth Score | Momentum Score | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|---|---|---|
TMOThermo Fisher Scientific, Inc. | D | C | A | 5.5x | 6.7% | 40.9% | 17.6% | $690.00 |
| ROKRockwell Automation, Inc. | D | C | B | 5.3x | 5.7% | 54.5% | 14.7% | $426.23 |
| TRMBTrimble Inc. Common Stock | C | C | B | 3.6x | -0.4% | 70.5% | 3.7% | $59.46 |
| ONTOOnto Innovation Inc. | D | B | C | 9.7x | 12.6% | 55.1% | 12.0% | $220.70 |
| MIRMirion Technologies, Inc. | C | B | C | 3.7x | 8.6% | 48.0% | 5.3% | $15.15 |
| QSIQuantum-Si Incorporated Class A Common Stock | D | F | C | 152.7x | — | 35.0% | -6887.8% | $1.12 |
| OWLTOwlet, Inc. | B | B | D | 1.0x | 7.0% | 54.8% | -8.4% | $4.11 |
| GEOSGeospace Technologies Corporation Common Stock | B | F | D | 0.6x | 4.8% | 8.0% | -44.6% | $4.41 |
| BCHTBirchtech Corp. | B | B | D | 1.6x | 16.6% | 39.7% | -23.6% | $1.18 |
| NIKINiki BioSolutions, Inc. Common Stock | — | — | F | 5.3x | — | 7.1% | -1298.4% | $2.03 |
| APMAptorum Group Limited Class A Ordinary Shares | C | — | D | 4.7x | — | 7.1% | -1298.4% | $4.82 |
About Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific supplies scientific instruments, laboratory equipment, diagnostics, and life science reagents to pharmaceutical, biotech, clinical, and academic research markets. The company operates through four segments: analytical technologies, specialty diagnostics, life science solutions, and lab products and services, which includes contract research operations.